| ncRNA name | hsa-miR-211 |
| ncRNA Category | miRNA |
| Disease name | diabetic retinopathy (DR) |
| Species | Homo sapiens |
| Tissues/Cell_line | serum, retinas; human umbilical vein endothelial cells (HUVECs) |
| Methods | microarray, qRT-PCR, Western blot, luciferase reporter assay, flow cytometry, CCK-8 assay |
| Expression pattern | up-regulated |
| Functional description | The current clinical study and experimental research imply that serum miR-211 as a novel biomarker with high sensitivity and specificity could be associated with occurrence and progression of DR via targeting SIRT1. |
| PubMed ID | 30333091 |
| Year | 2018 |
| Title | Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. |
| Drug-related ncRNA | NO |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.